-
-
-
-
-
-
-
Oculis Holding AG (OCS) PT Raised to $36 at H.C. Wainwright
-
-
-
-
-
-
-
Oculis Holding (OCS) Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Oculis Holding AG (OCS)
-
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

